MSK Nassau — Uniondale, New York

MSK Nassau is a clinical research site located in Uniondale, New York, United States 11553.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

MSK Nassau has participated in 19 clinical trials with 14 currently active.

Therapeutic areas: Muscle-invasive Urothelial Carcinoma, Multiple Myeloma, Colorectal Neoplasms.

Sponsors: Hoffmann-La Roche, Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Uniondale

Browse all research sites in New York · View every site in Uniondale

• Memorial Sloan Kettering Nassau
• Memorial Sloan Kettering Cancer Center Nassau
• Memorial Sloan Kettering at Nassau (Consent and Followup)
• Research Site
• Memorial Sloan Kettering
• Memorial Sloan Kettering Cancer Center
• Memorial Sloan Kettering Nassau - Limited Protocol Activities
• Memorial Sloan Kettering Cancer Center at Nassau
• Local Institution - 010-918 - E
• MSKCC Nassau Regional Cancer Center

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MSK Nassau?

MSK Nassau has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MSK Nassau conducted?

MSK Nassau has 19 clinical trials on record, with 14 currently active. Their work covers Muscle-invasive Urothelial Carcinoma, Multiple Myeloma, Colorectal Neoplasms.

Is MSK Nassau accredited by Crixeo Clinical Trials?

MSK Nassau has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MSK Nassau?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.